| 000 | 01803 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513003418.0 | ||
| 264 | 0 | _c19810224 | |
| 008 | 198102s 0 0 eng d | ||
| 022 | _a0036-553X | ||
| 024 | 7 |
_a10.1111/j.1600-0609.1981.tb01362.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNissen, N I | |
| 245 | 0 | 0 |
_aRadiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA. _h[electronic resource] |
| 260 |
_bScandinavian journal of haematology _cJul 1980 |
||
| 300 |
_a35-44 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMechlorethamine _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aProcarbazine _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aNordentoft, A M | |
| 700 | 1 | _aBrincker, H | |
| 700 | 1 | _aAndersen, E | |
| 700 | 1 | _aJensen, M K | |
| 700 | 1 | _aNielsen, J B | |
| 700 | 1 | _aPedersen-Bjergaard, J | |
| 700 | 1 | _aJensen, T S | |
| 700 | 1 | _aJensen, K B | |
| 700 | 1 | _aVidebaek, A | |
| 700 | 1 | _aPedersen, M | |
| 700 | 1 | _aWalbom-Jørgensen, S | |
| 773 | 0 |
_tScandinavian journal of haematology _gvol. 25 _gno. 1 _gp. 35-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.1981.tb01362.x _zAvailable from publisher's website |
| 999 |
_c7003366 _d7003366 |
||